UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in NUVB — Nuvation Bio Inc.
CIK 861177
NEW YORK, NY
Position in NUVB
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,197,168
-$2,471,329 QoQ
Shares Held
512,161
-1.7% QoQ
Ownership
0.147%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
18 quarters on record
Voting authority
Sole 41%
Shared 0%
None 59%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. NUVB ranks #99 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in NUVB
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,197,168 | 512,161 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $4,668,497 | 521,038 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,372,185 | 370,861 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,345,215 | 689,855 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $767,212 | 435,917 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $925,162 | 347,806 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $516,667 | 225,619 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $684,123 | 234,289 | Shares | Defined | 2024-08-14 | |
| 2023-09-30 | $239,611 | 178,816 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $321,867 | 178,816 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $296,833 | 178,816 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $281,450 | 146,590 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $318,917 | 142,374 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $515,846 | 159,212 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $684,935 | 130,216 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,106,835 | 130,216 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $884,510 | 88,985 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $828,450 | 88,985 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||